Jose Lozada Costas, MD
Hematology & Oncology Physician in San Juan, Puerto Rico.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 11,215 in Hematology & Oncology Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Source: CMS Medicare Part D Prescriber Public Use File, 2023
What the federal data shows
Jose Lozada Costas, MD filed 1,970 Medicare Part D claims in 2023 as a Hematology & Oncology Physician in San Juan, Puerto Rico, prescribing 70% generic.
- 2K
- Part D claims, 2023
- 70%
- generic prescribing
- $28.0K
- industry payments (Sunshine Act)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
Jose Lozada Costas, MD's Medicare Part D volume vs every U.S. prescriber
Total Medicare Part D claims, 2023, across all CMS prescribers nationally
1,970 Top 16% higher than 84% of 1,370,886 prescribers
Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source CMS Medicare Part D Prescriber Public Use File · 2023
Jose Lozada Costas, MD practices in an ABMS-board-eligible specialty but we don't have enough CMS-participation signals to confirm active board-certified status. Consult CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about Jose Lozada Costas, MD?
Quality data not reportedPrimary specialty
Medicare Part D claims
Specialty distribution in Puerto Rico
How Hematology & Oncology Physician compares to other specialties among Puerto Rico providers
Hematology & Oncology Physician ranks #55 among Puerto Rico's specialties (0.3% of in-state providers)
Each bar is a specialty's share of the Puerto Rico provider total, by primary NUCC taxonomy. The highlighted bar is Hematology & Oncology Physician; the long tail of smaller specialties is omitted for legibility.
Board certification
Not published by CMS
CMS does not publish a per-provider board-certification field in NPPES. PlainDoctor does not have a reliable per-specialty certification rate to show for Hematology & Oncology Physician. Verify directly:
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Jose Lozada Costas, MD appears in the CMS NPPES registry as a Hematology & Oncology Physician provider holding MD credentials at 576 CALLE CESAR GONZALEZ STE 503, San Juan, PR, 00918, with a listed phone of (787) 766-2083. NPI 1295713337 was issued on 01/09/2006.
Medicare Part D records for calendar year 2023 show 1,970 prescription claims written by this provider, covering 309 Medicare beneficiaries and totaling roughly $6.6 million in drug spend, split 30% brand-name and 70% generic by claim count, with an opioid prescribing rate of 2.4%.
Hematology & Oncology Physician is a mid-sized specialty nationwide, with 11,215 enrolled providers across 54 states and an average of 847 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline.
Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist, always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.
Practice Address
Provider Details
| NPI | 1295713337 |
|---|---|
| Specialty | Hematology & Oncology Physician |
| Credentials | MD |
| Gender | Male |
| NPI Issued | 01/09/2006 |
Verify this provider's license
PlainDoctor pulls this profile from the CMS NPPES public registry. Confirm Jose Lozada Costas, MD's current license status, disciplinary history, and board certifications directly with the licensing state's medical board before relying on this page for a clinical or care decision.
How we sourced this profile
Profile fields combine the CMS NPPES monthly snapshot (provider directory, taxonomy, and address) with calendar-year 2023 Medicare Part D and MIPS public-use files when records are present. NPI 1295713337 is the unique 10-digit identifier CMS uses to link Lozada Costas across every Medicare, Medicaid, and HIPAA-covered transaction. Read full methodology →
Industry payments received (2024) - CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for Jose Lozada Costas, MD. Source: openpaymentsdata.cms.gov.
Total received
$28.0K
Largest payer
Amgen Inc.
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias, they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
Brand vs generic prescribing mix · Above average
30% brand-name claims vs 70% generic, on 1,970 2023 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
Prescribing Breakdown
- 30-Day Fills
- 2,374
- Total Day Supply
- 67,614
- Brand vs Generic
- 30% brand / 70% generic
- Brand Drug Cost
- $6.4M
- Generic Drug Cost
- $135K
- Opioid Claims
- 48 (2.4% rate)
Patient Demographics
- Average Patient Age
- 74.0 years
- Avg HCC Risk Score
- 1.97
- Gender Split
- 76% female / 24% male
- Age Distribution
- <65: 28, 65-74: 136, 75-84: 113, 85+: 32
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
What Jose Lozada Costas, MD prescribes most
Top Medicare Part D drugs by claim count, 2023
- Anastrozole
Anastrozole
616 claims
- Raloxifene Hcl 179
Raloxifene Hcl
179 claims
- Xtandi 152
Xtandi
152 claims
- Exemestane 125
Exemestane
125 claims
- Dexamethasone 85
Dexamethasone
85 claims
- Hydroxyurea 85
Hydroxyurea
85 claims
- Ibrance 62
Ibrance
62 claims
- Retacrit 51
Retacrit
51 claims
| Drug | Claims |
|---|---|
| Anastrozole | 616 |
| Raloxifene Hcl | 179 |
| Xtandi Enzalutamide | 152 |
| Exemestane | 125 |
| Dexamethasone | 85 |
| Hydroxyurea | 85 |
| Ibrance Palbociclib | 62 |
| Retacrit Epoetin Alfa-Epbx | 51 |
| Prednisone | 42 |
| Revlimid Lenalidomide | 35 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Hematology & Oncology Physician Overview
How Jose Lozada Costas, MD fits within the Hematology & Oncology Physician landscape nationally.
Jose Lozada Costas, MD's 1,970 claims are above the specialty average of 847.
Nearby Hematology & Oncology Physician Providers in Puerto Rico
Other clinicians with the same primary specialty enrolled in Puerto Rico, drawn from the same CMS NPPES roster as Lozada Costas.
Compare Hematology & Oncology Physician nationally: see state-by-state distribution →
Before you book an appointment
Use this federal record as your verification checklist, not as a recommendation.
- Confirm the NPI record is current in the official CMS registry, providers update their own NPPES details, and moves can lag. Verify this NPI
- Check the active license and any disciplinary history with the Puerto Rico medical board, federal registration is not a license check. Credential verification guide
- Weigh a second option: compare this provider with a nearby Hematology & Oncology Physician peer on Medicare volume and prescribing patterns. Compare providers
Medicare Part D and MIPS figures describe practice patterns in federal programs only, they are not quality ratings, and PlainDoctor does not rate, rank, or recommend providers.
Healthcare Guides
Learn more about finding, verifying, and understanding healthcare providers.
Explore Puerto Rico
Frequently Asked Questions
What is Jose Lozada Costas, MD's specialty? ▼
How much does Jose Lozada Costas, MD prescribe under Medicare Part D? ▼
Where is Jose Lozada Costas, MD located? ▼
What is Jose Lozada Costas, MD's NPI number? ▼
Does Jose Lozada Costas, MD prescribe more brand-name or generic drugs? ▼
Does Jose Lozada Costas, MD prescribe opioids? ▼
How many Hematology & Oncology Physician providers are there in the US? ▼
What drugs does Jose Lozada Costas, MD prescribe most often? ▼
Does Jose Lozada Costas, MD accept Medicare? ▼
How can I verify Jose Lozada Costas, MD's credentials? ▼
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology